- Journey Medical Corporation
Journey Medical Corporation
9237 East Via de Ventura Boulevard
Website
Offer Price
Offer Size
3-Year Outlook
Volatility
1st Day Turnover
$10.00
3,520,000
Positive
High
109.92%
Offering Team
Deal Managers
- B Riley
Lawyers
- Alston & Bird LLP
Auditors
- KPMG LLP
Pre-IPO Investors
Investors
- Google Ventures
- Intel Ventures
- Patricoff Ventures
- Kleiner Perkins
Pre-IPO Holdings(%)
- 30
- 20
- 05
- 18
Deal Highlights
Journey Medical Corporation is a commercial-stage pharmaceutical company founded in October 2014 that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Our current portfolio includes five branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the U.S. We are managed by experienced life science executives with a track record of creating value for th More
Deal Tracker
Investors
Filing
10 Nov, 2021Offer
12 Nov, 2021Look Ahead
Lock Up Expiry
12 May, 2022Earning
Nov 1, 2018IPO Terms
Offer Price | $10.00 |
Offer Size | 3M |